托法替尼
耐受性
Janus激酶抑制剂
贾纳斯激酶
医学
皮肤病科
硬皮病(真菌)
少年
药理学
内科学
不利影响
免疫学
受体
生物
类风湿性关节炎
遗传学
接种
作者
М.К. Осминина,N.S. Podchernyaeva,V. A. Seraya,S.Kh. Kurbanova,O Batureva,S Chebusheva,О.В. Шпитонкова,A Polyanskaya,A. A. Skakodub,Nadezhda K. Ziskina
出处
期刊:PubMed
日期:2025-01-01
卷期号: (358): 26-30
摘要
Our case series showed a significant improvement in skin and joint damage after 12 months of TF therapy in resistant JLSL patients. Further experience with TF is needed to determine its place in the treatment of juvenile scleroderma.
科研通智能强力驱动
Strongly Powered by AbleSci AI